In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Amicus (FOLD – Research Report), with a price target of $20.00.

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...

News of a significant price-target boost from an analyst tracking GDS Holdings (NASDAQ: GDS) was the main catalyst behind the stock's jump on Monday. On Monday morning, TD Cowen's Michael Elias upped ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” ...

China-based GDS Holdings (GDS) is surging 6% after investment bank TD Cowen raised its price target on the shares. The ...

TD Cowen has downgraded Merck (NYSE:MRK) to hold from buy, citing Keytruda's impending loss of market exclusivity, or LOE. The bank said it no longer sees "viable arguments" for outperformance in the ...

TD Cowen's analysts adjusted their outlook on Neste Oyj (NESTE:FH) (OTC: NTOIY), reducing the price target from €19.00 to €15.00 while maintaining a Hold rating on the stock. The stock, currently ...

On Sunday, Trump said he would instruct the Treasury to stop minting pennies, calling the process wasteful. In particular, he flagged in a social media post that producing pennies "literally" costs ...

The New Hampshire-based company is opening new gyms around the country, spurred by a CEO change that has helped propel its ...